Senores Pharma Ends FY26 on High Note with Strong Financial Performance and Expansion Momentum

Ahmedabad, Gujarat, May 14, 2026 — Senores Pharmaceuticals Limited reported strong financial and operational performance for the fourth quarter and full year ended March 31, 2026, driven by sustained growth across regulated markets, emerging markets and branded generics businesses.

The research-driven pharmaceutical company posted consolidated total income of ₹664 crore for FY26, marking a 62% year-on-year increase. EBITDA rose 96% to ₹200 crore, while profit after tax (PAT) climbed 108% to ₹122 crore.

For Q4 FY26, total income stood at ₹190 crore, up 58% year-on-year. EBITDA increased 144% to ₹62 crore, while quarterly PAT rose 105% to ₹37 crore, reflecting improved operating leverage and execution.

The company also reported improved operating cash flow generation, with FY26 cash flow from operations reaching ₹75 crore, supported by stronger EBITDA-to-cash conversion.

Regulated Markets Lead Growth

Senores said its regulated markets business remained the key growth driver during the year.

Revenue from regulated markets rose 74.6% year-on-year to ₹427.4 crore in FY26, while Q4 revenue from the segment grew 83% to ₹117.8 crore.

The company now holds 51 approved ANDAs covering 151 strengths, more than double the 26 approved ANDAs it had as of March 2025. More than 30 approved ANDAs are yet to be commercialized, while 27 ANDAs involving over 65 strengths remain under development.

Emerging Markets and Branded Generics Expand

The emerging markets business continued to record steady growth, with FY26 revenue increasing 19.7% year-on-year to ₹145 crore. Q4 revenue from the segment rose 25.8% to ₹45.9 crore. EBITDA margins for the segment stood at approximately 12% during FY26.

Meanwhile, the company’s India-focused branded generics business delivered significant expansion. FY26 revenue surged nearly 385% year-on-year to ₹40 crore, while Q4 revenue rose 132.4% to ₹9.4 crore. The company said its portfolio has received approvals from several leading specialty and multi-specialty hospitals.

Strategic Acquisitions and U.S. Expansion

During FY26, Senores completed several strategic initiatives aimed at strengthening its global platform and improving long-term scalability.

The company completed Phase 1 acquisition of a 75% stake in Apnar Pharmaceuticals, with the remaining 25% expected to be completed by Q2 FY27. Product rollouts from the facility began in Q4 FY26, and the company expects the facility to scale significantly over the next 12 to 18 months while improving margins and expanding CDMO-CMO opportunities.

Senores also signed an agreement to acquire a 51% membership interest in Zoraya Pharmaceuticals LLC in the United States. The platform is expected to support vertical integration and commercialization of the company’s ANDA portfolio in the U.S. market.

In April 2026, the company established Amerisyn, a 70% joint venture in the United States, enabling direct participation in pharmaceutical supply opportunities for federal, veterans and defense sectors.

Management Commentary

Commenting on the performance, Managing Director Swapnil Shah said the company delivered robust growth despite an uncertain operating environment, supported by operational discipline and consistent execution.

Shah noted that the company’s approved ANDA portfolio more than doubled during FY26 and said the combination of approved products, ongoing development pipeline, manufacturing expansion and U.S. commercialization initiatives positions Senores for sustained long-term growth.

Outlook

Senores said it will continue focusing on expanding its regulated market pipeline, strengthening vertical integration, scaling its branded generics portfolio and improving profitability in emerging markets.

The company added that continued investments in product development, manufacturing capacity and global commercialization platforms are expected to support growth momentum in the coming years.

Government and NABARD reviews Cooperatives in Delhi: NABARD hosts First HLC Meeting for FY 2026-27

National Bank for Agriculture and Rural Development (NABARD), New Delhi Regional Office convened the 1st Meeting of the High-Level Committee (HLC) of the Financial Year 2026-27 for monitoring the performance of the Short-Term Cooperative Credit Structure (STCCS) in. The meeting was chaired by Sri Pandurang K Pole, IAS, Secretary (Cooperation), GNCT of Delhi. The meeting was attended by Shri Eda Raja Babu, IAS, Special RCS, GNCTD, Sri Ashok Kumar, General Manager, RBI New Delhi, Sri Nabin Kumar Roy, CGM, NABARD, New Delhi RO and Shri Rajiv Kumar Kadyan, MD (Officiating), Delhi State Cooperative Bank (DStCB) and other Senior Officials from RBI, NABARD.

The HLC ensures continuous supervision, regulatory compliance, and improvement of the cooperative banking system in Delhi.

The Committee deliberated upon the financial performance of Delhi State Cooperative Bank Ltd., status of it’s compliance with Statutory and Regulatory provisions, review of status of it’s Internal Checks & Controls, strengthening Grievance Redressal Mechanisms, Governance and HR issues, technology upgradation & financial inclusion.

Chairing the meeting Shri Pandurang K Pole, IAS, Secretary (Cooperation), GNCT of Delhi, opined that Delhi State Cooperative Bank should diversify its activities and work on various digital modules to enhance the banking footprints of the bank. He also advised RCS office to extend adequate support to DStCB and NABARD.

The Committee reaffirmed its dedication to enhancing Delhi’s Rural Cooperative Banking framework by focusing on stronger governance, embracing modern technology, ensuring stricter financial discipline and driving reforms for better customer satisfaction.

Executive Chef Appointment | voco Amritsar appoints Sumit Kumar as Executive Chef

voco Amritsar appoints Sumit Kumar as Executive Chef A seasoned culinary expert, Sumit Kumar will drive innovation across dining and banqueting experiences

National, 14 May 2026: voco Amritsar has announced the appointment of Sumit Kumar as Executive Chef. In his new role, he will spearhead culinary strategy and operations across the hotel’s restaurants, in-room dining and banqueting spaces. Sumit will also be heading the menu development, kitchen standards, team training and guest dining experiences at voco Amritsar.

Chef Sumit brings over 16 years of international culinary experience, specialising in Italian and Progressive Indian cuisine. Over the course of his career, he has worked with leading hospitality brands including ITC Hotels, Hyatt, Radisson Hotel Group, Marriott International and IHG Hotels & Resorts.

His professional journey has also taken him across international destinations such as Saudi Arabia, Dubai, England and Japan, where he gained valuable exposure to diverse culinary traditions and global dining standards.

Speaking on the appointment, Manish Yadav, General Manager, voco Amritsar, said: “Culinary experiences play a vital role in shaping memorable guest stays, and at voco Amritsar, this remains a key focus. Chef Sumit’s global exposure, creativity, and leadership will further strengthen the hotel’s dining and banqueting offerings. The team is delighted to welcome him on board and looks forward to the innovation and excellence he will bring to the culinary experiences at voco Amritsar.

Commenting on his new role, Chef Sumit Kumar said: “I am excited to join voco Amritsar, a brand known for its warm hospitality and vibrant guest experiences. I look forward to working with the team to craft menus that celebrate seasonal ingredients, refined techniques and global flavours, while creating memorable dining experiences for our guests.”

Sumit is passionate about discovering new ingredients, exploring diverse cuisines, and immersing himself in culinary traditions from around the world. His culinary philosophy is guided by a strong focus on authenticity, craftsmanship, and a deep respect for locally sourced produce. At voco Amritsar, Sumit Kumar will helm the kitchen brigade, curating distinctive dining experiences while bringing voco’s core philosophy of ‘reliably different’ to life through thoughtfully crafted gastronomic offerings.

Indian Markets Rebound as Domestic Flows Stay Strong Despite Global Risks

India’s equity markets staged a sharp recovery in April 2026, supported by resilient domestic inflows, improving earnings expectations and hopes of easing geopolitical tensions in the Middle East, according to Tata Mutual Fund’s latest “Equity View” report for May 2026.

The Nifty 50 climbed 7.46% during April to close at 23,997, while the Sensex gained 6.9%, reversing part of the correction seen earlier this year. The report said bullish sentiment returned as volatility eased and investors priced in a potential stabilization in crude oil prices.

Broader markets outperformed benchmark indices during the month. The Nifty Midcap 150 surged 13.24% in April, while the Nifty Smallcap 250 jumped 17.1%, reflecting renewed risk appetite among investors.

However, the report cautioned that large-cap stocks currently offer better risk-reward opportunities than mid- and small-caps due to more reasonable valuations and stronger earnings visibility.

Domestic Investors Continue to Anchor Markets

Domestic institutional investors (DIIs) remained a major support for Indian equities even as foreign institutional investors (FIIs) continued to pull money out of the market.

FIIs were net sellers to the tune of $5.9 billion in April 2026 amid concerns over rising crude prices, geopolitical tensions and weakness in the rupee. In contrast, DIIs recorded inflows of $5.4 billion during the month, taking total domestic inflows in calendar year 2026 to $32.6 billion.

The report highlighted the growing influence of domestic mutual funds in Indian equities. Mutual funds now own 11.3% of India’s total market capitalization, up sharply from 4.3% a decade ago. Assets under management have climbed to nearly $800 billion, driven largely by strong retail participation and systematic investment plans (SIPs).

Banking, Manufacturing and Pharma Seen as Key Growth Drivers

Tata Mutual Fund expects corporate earnings growth to recover in FY27 after downgrades in FY25 and FY26. The report identified banking, manufacturing, capital goods and pharmaceuticals as sectors likely to benefit from the next phase of growth.

Banks are projected to deliver 15-20% growth in FY27, supported by improving credit demand, benign asset quality trends and recovery in net interest margins after expected bottoming out in FY26.

Credit growth has already shown signs of acceleration. Bank credit expanded to 17.1% in March 2026 as rising government bond yields made bank borrowing cheaper than bond issuances for corporates. The report expects retail lending, infrastructure financing and MSME borrowing to remain key growth drivers going forward.

Meanwhile, capital goods and utilities continued to gain weight in mutual fund portfolios. Allocation to capital goods rose to a 17-month high of 7.8% in April, while utilities climbed to a 19-month high of 3.9%. Technology sector allocation, however, dropped to an eight-year low.

Crude Oil and Geopolitics Remain Key Risks

Despite optimism around domestic growth, the report flagged crude oil prices and global geopolitical developments as the biggest near-term risks for Indian markets.

Brent crude averaged $121.63 per barrel in April 2026 following supply disruptions and infrastructure damage in the Middle East. Global crude supply reportedly fell to 97 million barrels per day in March from 107 million barrels per day in February due to regional conflict.

The report warned that India remains vulnerable to higher oil prices because of its dependence on imports, adding that rising crude and geopolitical uncertainty also contributed to rupee weakness. The Indian currency averaged 93.31 against the U.S. dollar in April and remained among the weakest-performing Asian currencies over the past year.

GDP Outlook Remains Strong

India’s macroeconomic outlook remains resilient despite global uncertainty, the report said. The Reserve Bank of India expects GDP growth of 7.4% in FY26 and 6.9% in FY27, supported by domestic demand, agricultural recovery, construction activity and resilient services growth.

Inflation also remained relatively contained, with consumer price inflation at 3.4% in April 2026, while the RBI kept the repo rate unchanged at 5.25% during its latest monetary policy meeting.

India’s foreign exchange reserves rose to $690.69 billion in April, providing a strong external buffer amid currency volatility and global uncertainty.

Valuations Turn More Reasonable

The report said Indian equities are now trading at more reasonable valuations after recent corrections. The Nifty 50’s one-year forward price-to-earnings multiple stood at around 19.1x, below its 10-year average of approximately 21x.

While India still trades at a premium to other emerging markets, that premium has narrowed considerably. The Nifty 50’s valuation premium over the MSCI Emerging Markets index declined to 60.2% by the end of April 2026 from 77% in March 2025.

The report concluded that a balanced portfolio approach with greater emphasis on large-cap stocks, selective exposure to mid- and small-caps, and a focus on earnings upgrades could help investors navigate a range-bound but improving market environment.